SEC23A and cancer: The correlations between SEC23A expression level and TMB, MSI, stemness score, and drug sensitivity (Antitumor agents) were too low to be considered significant in all cancer types included in the analysis (section “Materials and Methods,” Figures 3A–D; Supplementary Table 2).